Profitelligence Profitelligence · Filing Ledger Search all insiders →

Insider Profile · SEC Form 4 Activity · Trailing 90 Days

Tetrault Lynn A.

Over the trailing 90 days, Tetrault Lynn A. (Director at RHYTHM PHARMACEUTICALS, INC.) traded $4.9M of stock (net selling $2.8M) across 3 companies, per 15 SEC Form 4 transactions.

Role
Director
Companies
RYTM NEO ALMS
Window
Trailing 90 days · 15 transactions · CIK 1645512
Net activity
−$2.8M ($1.0M bought · $3.8M sold)

By Company (Trailing 90 Days)

SymbolCompanyTxnsBoughtSoldNet
RYTMRHYTHM PHARMACEUTICALS, INC.7$1.0M$3.7M−$2.7M
NEONEOGENOMICS INC6$119K−$119K
ALMSALUMIS INC.2$0

Transactions (15)

DateSymbolTypeSharesValueDescription
2026-06-30ALMSBuy15.5K$0Grant, award or other acquisition
2026-06-30ALMSBuy3.6K$0Grant, award or other acquisition
2026-06-24RYTMBuy3.7K$0Grant, award or other acquisition
2026-06-24RYTMBuy2.3K$0Grant, award or other acquisition
2026-06-23RYTMSell4.7K$0Exercise or conversion of derivative security
2026-06-23RYTMBuy4.7K$0Exercise or conversion of derivative security
2026-06-22RYTMSell37.0K$0Exercise or conversion of derivative security
2026-06-22RYTMBuy37.0K$1.0MExercise or conversion of derivative security
2026-06-22RYTMSell37.0K$3.7MOpen market or private sale
2026-06-15NEOSell5.3K$59KOpen market or private sale
2026-06-09NEOSell5.3K$60KOpen market or private sale
2026-06-01NEOBuy11.1K$0Grant, award or other acquisition
2026-06-01NEOSell23.1K$0Exercise or conversion of derivative security
2026-06-01NEOBuy16.0K$0Grant, award or other acquisition
2026-06-01NEOBuy23.1K$0Exercise or conversion of derivative security

Activity shown covers the trailing 90 days of SEC Form 4 filings. "Buy" and "sell" follow the SEC acquired/disposed codes and include compensation events (grants, option exercises, tax withholding) unless noted. Historical fact, not investment advice.

Follow Tetrault's next move

Real-time Form 4 alerts, insider track records, and cluster detection — matched to your watchlist.

Start free